1. Home
  2. AMRX vs AB Comparison

AMRX vs AB Comparison

Compare AMRX & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.29

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Logo AllianceBernstein Holding L.P.

AB

AllianceBernstein Holding L.P.

HOLD

Current Price

$35.81

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
AB
Founded
2002
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.5B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
AMRX
AB
Price
$17.29
$35.81
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$15.60
$40.40
AVG Volume (30 Days)
1.9M
334.7K
Earning Date
05-01-2026
04-28-2026
Dividend Yield
N/A
8.59%
EPS Growth
157.89
N/A
EPS
0.19
N/A
Revenue
N/A
N/A
Revenue This Year
$4.48
N/A
Revenue Next Year
$7.13
$6.45
P/E Ratio
$91.13
$13.85
Revenue Growth
N/A
N/A
52 Week Low
$7.67
$34.92
52 Week High
$17.78
$44.11

Technical Indicators

Market Signals
Indicator
AMRX
AB
Relative Strength Index (RSI) 82.12 37.63
Support Level $12.46 $35.59
Resistance Level N/A $39.62
Average True Range (ATR) 0.64 0.66
MACD 0.16 -0.03
Stochastic Oscillator 85.34 34.60

Price Performance

Historical Comparison
AMRX
AB

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About AB AllianceBernstein Holding L.P.

AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (41%), and private (18%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of February 2026, the company had $880.0 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (40%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.

Share on Social Networks: